The city of Salvador, Brazil, has launched its vaccination program against dengue, utilizing a vaccine that is entirely produced by the Instituto Butantan in Brazil. This initiative kicked off on Monday, with an initial 2,648 doses distributed by the federal government. The focus during this initial phase is on vaccinating healthcare workers, including doctors, nurses, and community health agents, who are crucial in the fight against the dengue outbreak.

The municipal health department has outlined that the target group for the first batch of vaccines consists of professionals from various sectors within primary health care. This includes not only frontline health workers such as physicians and nurses but also a range of other healthcare professionals like nutritionists, psychologists, and physical educators, among others. The vaccination strategy is aligned with guidelines from Brazil's Ministry of Health and aims to reduce the incidence of dengue through immunization of those most likely to come into contact with infected individuals.

Looking forward, the Municipal Health Secretariat anticipates receiving additional vaccine supplies from the Ministry of Health, which will allow them to expand the vaccination drive to other populations. The proactive approach taken by Salvador's administration underscores their commitment to tackling health issues head-on and reflects broader national efforts to curb dengue outbreaks in Brazil, a country that has faced significant challenges with this mosquito-borne disease in recent years.